[1]
“ Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction ”, Braz. J. Pharm. Sci., vol. 45, no. 4, pp. 619–624, Dec. 2009, doi: 10.1590/S1984-82502009000400003.